These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10564839)

  • 1. Pulmonary delivery of a dopamine D-1 agonist, ABT-431, in dogs and humans.
    Zheng Y; Marsh KC; Bertz RJ; El-Shourbagy T; Adjei AL
    Int J Pharm; 1999 Nov; 191(2):131-40. PubMed ID: 10564839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the AERx pulmonary delivery system for systemic delivery of a poorly soluble selective D-1 agonist, ABT-431.
    Okumu FW; Lee RY; Blanchard JD; Queirolo A; Woods CM; Lloyd PM; Okikawa J; Gonda I; Farr SJ; Rubsamen R; Adjei AL; Bertz RJ
    Pharm Res; 2002 Jul; 19(7):1009-12. PubMed ID: 12180532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.
    Shiosaki K; Jenner P; Asin KE; Britton DR; Lin CW; Michaelides M; Smith L; Bianchi B; Didomenico S; Hodges L; Hong Y; Mahan L; Mikusa J; Miller T; Nikkel A; Stashko M; Witte D; Williams M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):150-60. PubMed ID: 8558425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
    Rascol O; Nutt JG; Blin O; Goetz CG; Trugman JM; Soubrouillard C; Carter JH; Currie LJ; Fabre N; Thalamas C; Giardina WW; Wright S
    Arch Neurol; 2001 Feb; 58(2):249-54. PubMed ID: 11176963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431.
    Shiosaki K; Asin KE; Britton DR; Giardina WJ; Bednarz L; Mahan L; Mikusa J; Nikkel A; Wismer C
    Eur J Pharmacol; 1996 Dec; 317(2-3):183-90. PubMed ID: 8997599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data.
    Giardina WJ; Williams M
    CNS Drug Rev; 2001; 7(3):305-16. PubMed ID: 11607045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers.
    Zheng JY; Fulu MY; Lee DY; Barber TE; Adjei AL
    Pharm Dev Technol; 2001 Nov; 6(4):521-30. PubMed ID: 11775953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.
    Elshoff JP; Cawello W; Andreas JO; Mathy FX; Braun M
    Drugs; 2015 Apr; 75(5):487-501. PubMed ID: 25795100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431).
    Michaelides MR; Hong Y; DiDomenico S; Asin KE; Britton DR; Lin CW; Williams M; Shiosaki K
    J Med Chem; 1995 Sep; 38(18):3445-7. PubMed ID: 7658429
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation.
    Rabinowitz JD; Lloyd PM; Munzar P; Myers DJ; Cross S; Damani R; Quintana R; Spyker DA; Soni P; Cassella JV
    J Pharm Sci; 2006 Nov; 95(11):2438-51. PubMed ID: 16886198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations.
    Elshoff JP; Timmermann L; Schmid M; Arth C; Komenda M; Brunnert M; Bauer L
    Curr Med Res Opin; 2013 Dec; 29(12):1657-62. PubMed ID: 24006953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative morphometric analysis of pulmonary deposition of aerosol particles inhaled via intratracheal nebulization, intratracheal instillation or nose-only inhalation in rats.
    Leong BK; Coombs JK; Sabaitis CP; Rop DA; Aaron CS
    J Appl Toxicol; 1998; 18(2):149-60. PubMed ID: 9570698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotigotine: a novel dopamine agonist for the transdermal treatment of Parkinson's disease.
    Zareba G
    Drugs Today (Barc); 2006 Jan; 42(1):21-8. PubMed ID: 16511608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal administration of radiolabelled [14C]rotigotine by a patch formulation: a mass balance trial.
    Cawello W; Wolff HM; Meuling WJ; Horstmann R; Braun M
    Clin Pharmacokinet; 2007; 46(10):851-7. PubMed ID: 17854234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine.
    Elshoff JP; Cawello W; Andreas JO; Braun M
    Clin Pharmacol Drug Dev; 2014 May; 3(3):187-93. PubMed ID: 27128608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma scintigraphic evaluation of a miniaturized AERx pulmonary delivery system for aerosol delivery to anesthetized animals using a positive pressure ventilation system.
    Deshpande DS; Blanchard JD; Schuster J; Fairbanks D; Hobbs C; Beihn R; Densmore C; Farr S; Gonda I
    J Aerosol Med; 2005; 18(1):34-44. PubMed ID: 15741772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective dopamine D1 receptor agonist A-86929 maintains efficacy with repeated treatment in rodent and primate models of Parkinson's disease.
    Asin KE; Domino EF; Nikkel A; Shiosaki K
    J Pharmacol Exp Ther; 1997 Apr; 281(1):454-9. PubMed ID: 9103530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans.
    Haney M; Collins ED; Ward AS; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 1999 Mar; 143(1):102-10. PubMed ID: 10227086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pulmonary absorption of aerosolized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSF.
    Niven RW; Whitcomb KL; Shaner L; Ip AY; Kinstler OB
    Pharm Res; 1995 Sep; 12(9):1343-9. PubMed ID: 8570533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, disposition, metabolic fate, and elimination of the dopamine agonist rotigotine in man: administration by intravenous infusion or transdermal delivery.
    Cawello W; Braun M; Boekens H
    Drug Metab Dispos; 2009 Oct; 37(10):2055-60. PubMed ID: 19608695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.